Back to CTMX
CITADEL ADVISORS LLC CTMX Position History
CytomX Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$332K
Q2 2026
Peak value
$21.4M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $21.4M |
| Q1 2026 | $642K |
| Q1 2026 | $4M |
| Q1 2026 | $1.7M |
| Q2 2026 | $11.7M |
| Q2 2026 | $491K |
| Q2 2026 | $1K |
| Q2 2026 | $332K |
| Q2 2026 | $11.7M |
| Q2 2026 | $491K |
| Q2 2026 | $1K |
| Q2 2026 | $332K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $332K | 88.6K | — | — |
| Q2 2026 | $1K | 339 | — | — |
| Q2 2026 | $491K | 131.0K | — | — |
| Q2 2026 | $11.7M | 3.11M | — | — |
| Q2 2026 | $332K | 88.6K | — | — |
| Q2 2026 | $1K | 339 | — | — |
| Q2 2026 | $491K | 131.0K | — | — |
| Q2 2026 | $11.7M | 3.11M | — | — |
| Q1 2026 | $1.7M | 356.4K | — | — |
| Q1 2026 | $4M | 843.9K | — | — |
| Q1 2026 | $642K | 136.6K | — | — |
| Q1 2026 | $21.4M | 4.56M | — | — |